Studies how people with long-term cancer treatments are supported over time
Observes people with advanced chronic cancers taking newer targeted treatments for months or years.
Plain-language title generated from the registry record
Registry title: LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Key facts
- Where
- Edmonton, CanadaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with advanced chronic cancers who are taking long-term targeted anti-cancer treatments.
- Age
- 18 Years to 90 Years
- Sex
- All sexes can join.
- Disease stage
- Advanced chronic cancer (for example breast cancer, melanoma, multiple myeloma, chronic leukemia, prostate cancer, ovarian cancer, colorectal cancer or lung cancer).
- Earlier treatment
- Must be taking chronic targeted anti-cancer agents.
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT05645510, who can take part
Where in Canada
- Edith PituskinEdmonton, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Alberta
- Trial code
- NCT05645510
- Record updated
- 11 May 2026
- Original description
People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.Read full original descriptionShow less
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.
Exclusion: -.